Literature DB >> 12234549

The Gravettian occipital bone from the site of Malladetes (Barx, Valencia, Spain).

Juan Luis Arsuaga1, Valentín Villaverde, Rolf Quam, Ana Gracia, Carlos Lorenzo, Ignacio Martínez, José-Miguel Carretero.   

Abstract

The juvenile occipital bone from the site of Malladetes in Valencia (Spain) is described and compared with other European Pleistocene representatives of the genus Homo. This specimen derives from a Gravettian cultural context and has been AMS radiocarbon-dated to 25,120 +/- 240 years BP. As such, it provides evidence on early modern human anatomy from the Central Mediterranean region of the Iberian peninsula. The clear evidence for a late survival of Neandertals in southern Iberia, has led to considerable debate surrounding the biological and cultural interactions between these Pleistocene humans and their early modern human successors, and it is within this context that the Malladetes specimen represents an important contribution to the discussion. The recently discovered Upper Paleolithic infant from the site of Lagar Velho in Portugal is said to show a mosaic of Neandertal and early modern human characteristics throughout the skeleton and is argued to represent the strongest evidence yet recovered in favor of hybridization between these two Pleistocene populations. Our analysis of the Malladetes occipital, however, reveals no evidence of Neandertal genetic influence.

Entities:  

Mesh:

Year:  2002        PMID: 12234549     DOI: 10.1006/jhev.2002.0579

Source DB:  PubMed          Journal:  J Hum Evol        ISSN: 0047-2484            Impact factor:   3.895


  1 in total

1.  Anatomically modern human in Southeast Asia (Laos) by 46 ka.

Authors:  Fabrice Demeter; Laura L Shackelford; Anne-Marie Bacon; Philippe Duringer; Kira Westaway; Thongsa Sayavongkhamdy; José Braga; Phonephanh Sichanthongtip; Phimmasaeng Khamdalavong; Jean-Luc Ponche; Hong Wang; Craig Lundstrom; Elise Patole-Edoumba; Anne-Marie Karpoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.